ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$19.29 USD
-0.74 (-3.69%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $19.34 +0.05 (0.26%) 6:50 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $0.13 | 0.00% |
Earnings Summary
For their last quarter, ADMA Biologics (ADMA) reported earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.08 per share. This reflects a positive earnings surprise of 62.50%. Look out for ADMA's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $0.13 per share, reflecting a year-over-year increase of 1200%.
Earnings History
Price & Consensus
Zacks News for ADMA
ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest?
ADMA: What are Zacks experts saying now?
Zacks Private Portfolio Services